Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This randomised controlled trial has a non-inferiority design. The aim is to test if the blood loss (volume in mL and hemoglobin) is effected by heart and lung cardiotomy retransfusion, or not? Forty CABG (Coronary Artery By pass Grafting) patients will be allocated to either receive retransfusion (n=20) of cardiotomy blood via the heart and lung mashine, or no retransfusion (n=20).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Retransfusion of cardiotomy blood or not | Experimental | Intervention group does not get cardiotomy blood retransfusion via heart-and lung machine while control does. |
|
| No retransfusion of cardiotomy blood | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No retransfusion of cardiotomy blood | Procedure | No retransfusion of cardiotomy blood via heart- and lung mashine |
|
| Measure | Description | Time Frame |
|---|---|---|
| blood loss | Hemoglobin | During 5 days hemoglobin will be measured as the clinical rutine or as needed. |
| Blood loss | Blood volume in millilitre (mL) | During 2 days or while surgical drains remains, blood volume in mL is measured. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Camilla Wistrand, PhD | Contact | +460707686938 | camilla.wistrand@regionorebrolan.se |
| Name | Affiliation | Role |
|---|---|---|
| Camilla Wistrand, PhD | Örebro University, Sweden | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital in Örebro | Örebro | 70185 | Sweden |
The datasets generated and/or analysed during the current study are not publicly available due to ethical considerations of the participant integrity. Bacterial growth can be seen as sensitive data. The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016063 | Blood Loss, Surgical |
| ID | Term |
|---|---|
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D007431 | Intraoperative Complications |
Not provided
Not provided
Randomised controlled non-inferiority trial
Not provided
Not provided
The person that controle the heart- and lung mashine is not masked. Other members of the surgical team is masked.